$415 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 69 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 45.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | Neurocrine Biosciences Inc | $27,740,000 | +37.8% | 289,500 | +39.9% | 6.69% | +25.9% |
| AMGN | Buy | Amgen Inc | $25,146,000 | +102.3% | 118,300 | +132.0% | 6.06% | +84.8% |
| INCY | Buy | Incyte Corp | $18,590,000 | +61.5% | 270,360 | +97.5% | 4.48% | +47.6% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $17,419,000 | +538.1% | 98,500 | +482.8% | 4.20% | +482.7% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $14,007,000 | +7.2% | 77,222 | +19.1% | 3.38% | -2.1% |
| ILMN | New | ILLUMINA INC | $10,944,000 | – | 27,000 | +100.0% | 2.64% | – |
| EXEL | Buy | Exelixis Inc | $10,344,000 | +459.1% | 489,534 | +382.1% | 2.50% | +411.3% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,286,000 | +62.0% | 103,100 | +71.5% | 2.24% | +48.1% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $9,217,000 | -2.8% | 138,741 | +14.2% | 2.22% | -11.2% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $9,215,000 | +3055.8% | 380,000 | +1800.0% | 2.22% | +2787.0% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $9,020,000 | +92.5% | 236,000 | +42.2% | 2.18% | +75.9% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $7,934,000 | +27.3% | 297,500 | +47.0% | 1.91% | +16.3% |
| CCXI | Buy | CRISPR THERAPEUTICS AGnamen akt | $7,131,000 | +76.4% | 94,300 | +62.3% | 1.72% | +61.2% |
| KALV | Buy | Kalvista Pharmaceuticals Inc | $6,687,000 | -1.5% | 383,233 | +35.3% | 1.61% | -10.0% |
| INSM | Buy | INSMED INC | $6,637,000 | +133.0% | 241,100 | +140.9% | 1.60% | +112.9% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $5,755,000 | +62.0% | 44,200 | +121.0% | 1.39% | +48.0% |
| ASND | Buy | Ascendis Pharma ASsponsored adr | $4,686,000 | +158.2% | 29,400 | +113.0% | 1.13% | +135.9% |
| GH | Buy | GUARDANT HEALTH INC | $4,563,000 | +116.1% | 36,500 | +114.7% | 1.10% | +97.3% |
| ZLAB | Buy | ZAI LAB LTDadr | $4,098,000 | +81.0% | 38,958 | +204.4% | 0.99% | +65.2% |
| DYN | Buy | DYNE THERAPEUTICS INC | $4,060,000 | +43.0% | 250,000 | +85.2% | 0.98% | +30.5% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $2,992,000 | +24.0% | 235,000 | +37.6% | 0.72% | +13.3% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $2,778,000 | – | 109,000 | +100.0% | 0.67% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $2,497,000 | – | 49,500 | +100.0% | 0.60% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $2,263,000 | +51.1% | 40,000 | +17.5% | 0.55% | +38.2% |
| ZGNX | New | ZOGENIX INC | $2,051,000 | – | 135,000 | +100.0% | 0.50% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $1,883,000 | – | 63,000 | +100.0% | 0.45% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $1,696,000 | – | 215,000 | +100.0% | 0.41% | – |
| FATE | New | FATE THERAPEUTICS INC | $1,660,000 | – | 28,000 | +100.0% | 0.40% | – |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $1,582,000 | – | 25,000 | +100.0% | 0.38% | – |
| KOD | New | KODIAK SCIENCES INC | $1,553,000 | – | 16,200 | +100.0% | 0.38% | – |
| IMAB | Buy | I MABsponsored ads | $1,301,000 | +158.6% | 18,000 | +200.0% | 0.31% | +136.1% |
| RLMD | New | RELMADA THERAPEUTICS INC | $261,000 | – | 10,000 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.